Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/8/9/893/19481240/8-9-893.pdf
Reference20 articles.
1. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children;Patte;J Clin Oncol,1991
2. Non-Hodgkin’s lymphomas of childhood and adolescence: Results of a treatment stratified for biological subtypes and stage;Reiter;A report of the Berlin-Frankfurt-Mūnster group. J Clin Oncol,1995
3. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen;Magrath;J Clin Oncol,1996
4. HiC-COM: A 2 month intensive chemotherapy regimen for children with stage III and IV Burkitt’s lymphoma and B-cell acute lymphoblastic leukemia;Schwenn;J Clin Oncol,1991
5. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group;Reiter;Blood,1992
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Primary extranodal diffuse large B cell lymphoma: a rare differential diagnosis of bilateral ovarian masses in the pediatric age group;Chirurgia;2022-11
2. Clinicopathologic Profile and Treatment Outcomes of Children With Diffuse Large B-cell Lymphomas: Experience From a Tertiary Cancer Center in India;Journal of Pediatric Hematology/Oncology;2022-02-03
3. Childhood aggressive B‐cell non‐Hodgkin lymphoma in low–middle‐income countries;British Journal of Haematology;2021-12-06
4. Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience;Pediatric Hematology and Oncology;2021-03-01
5. Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in India;Pediatric Blood & Cancer;2020-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3